The policy, once implemented, will allow chain and independent pharmacies to stock and dispense mifepristone to pregnant people with a prescription. | Credit: Allen G. Breed/AP Photo

The FDA on Tuesday updated a rule allowing brick-and-mortar pharmacies to dispense the abortion pill mifepristone — expanding access to the drug amid a wave of state efforts last year to impose restrictions.

Pharmacies in more than a dozen states that have near-total abortion bans would not be able to participate and those in states without bans would have to go through a certification process to qualify.

The Biden administration took a major step to open up access in 2021, making permanent pandemic-era rules allowing people to access the pill within the first 10 weeks of pregnancy via telemedicine and mail delivery. But the FDA’s proposed rule opens new legal and regulatory fronts in the ongoing battle over abortion following the fall of Roe v. Wade, and is likely to draw lawsuits from anti-abortion groups and state officials.

What’s in the rule: The policy, once implemented, will allow chain and independent pharmacies […]

Read the Full Article